Molecular Dysfunction and Phenotypic Derangement in Diabetic Cardiomyopathy

Area of Science:

• Cardiology
• Endocrinology
• Molecular Biology

Background:

• Diabetic cardiomyopathy (DCM) significantly impacts heart failure (HF) incidence and prognosis in diabetic (DM) patients.
• DCM affects 15-20% of the diabetic population, independent of coronary artery disease (CAD).
• Pathogenesis involves myocardial hypertrophy, fibrosis, oxidative stress, and vascular inflammation.

Purpose of the Study:

• To elucidate the diverse subtypes of diabetic cardiomyopathy.
• To detail the underlying pathophysiological mechanisms of DCM.
• To correlate molecular alterations with macroscopic structural changes in the heart.

Main Methods:

• Review of existing literature on diabetic cardiomyopathy.
• Analysis of molecular and cellular alterations associated with hyperglycemia.
• Examination of signaling pathways involved in cardiac remodeling.

Main Results:

• Hyperglycemia-induced changes include mitochondrial dysfunction, increased reactive oxygen species (ROS), and altered nitric oxide signaling.
• Mechanisms promote collagen deposition, leading to myocardial stiffness.
• DCM presents varied phenotypes (dilated or concentric), and its causal role in HF requires further clarification.

Conclusions:

• Diabetic cardiomyopathy is a distinct cardiac remodeling process in diabetes.
• Understanding DCM subtypes and molecular pathways is crucial for managing HF in diabetic patients.
• Further research is needed to clarify DCM's role in HF development and progression.